MacroGenics
MGNX
#8653
Rank
$0.23 B
Marketcap
$3.70
Share price
-7.73%
Change (1 day)
121.56%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : $0.19 Billion USD

According to MacroGenics's latest financial reports the company's total liabilities are $0.19 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31$0.20 B38.23%
2024-12-31$0.14 B-0.14%
2023-12-31$0.14 B5.31%
2022-12-31$0.13 B44.79%
2021-12-31$95.62 M15.41%
2020-12-31$82.85 M1.2%
2019-12-31$81.87 M-8.27%
2018-12-31$89.25 M19.57%
2017-12-31$74.64 M75.59%
2016-12-31$42.51 M-7.45%
2015-12-31$45.93 M-12.68%
2014-12-31$52.6 M12.23%
2013-12-31$46.86 M-24.39%
2012-12-31$61.98 M-22.68%
2011-12-31$80.16 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
$117.21 B 59,497.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$85.37 B 43,310.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$83.31 B 42,261.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$32.84 B 16,601.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$82.75 B 41,976.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$66.37 B 33,648.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
$0.22 B 12.48%๐Ÿ‡บ๐Ÿ‡ธ USA